Ionis Pharmaceuticals
Utility Patents
Last updated:
List of all Ionis Pharmaceuticals patents 19 in total
| Status | Patent |
|---|---|
Grant | Utility: Modulators of diacyglycerol acyltransferase 2 (DGAT2) Filling date: 8 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Compounds and methods for modulating SMN2 Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: 5' modified nucleosides and oligomeric compounds prepared therefrom Filling date: 8 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Compounds and methods for modulating UBE3A-ATS Filling date: 8 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Compounds and methods for modulating C90RF72 Filling date: 8 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Modulators of IRF4 expression Filling date: 8 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Modulation of GYS1 expression Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Modulators of YAP1 expression Filling date: 8 Sep 2025 Issue date: 4 Jan 2022 |
Grant | Utility: Modulation of the notch signaling pathway for treatment of respiratory disorders Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Combinations for the modulation of SMN expression Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Morpholino modified oligomeric compounds Filling date: 8 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Compositions and methods for modulating Tau expression Filling date: 8 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: Modulation of angiopoietin-like 3 expression Filling date: 8 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Conjugated antisense compounds and their use Filling date: 8 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Compositions for modulating Ataxin 2 expression Filling date: 8 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom Filling date: 8 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Compounds and methods for reducing ATXN2 expression Filling date: 8 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Compositions comprising alternating 2'-modified nucleosides for use in gene modulation Filling date: 8 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Compositions and their uses directed to huntingtin Filling date: 8 Sep 2025 Issue date: 27 Jul 2021 |
Showing 1 to 19 of 19 patents.